{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T20:59:31Z","timestamp":1791147571047,"version":"4.1.0"},"reference-count":85,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis Supplements"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.atherosclerosissup.2012.10.021","type":"journal-article","created":{"date-parts":[[2013,1,26]],"date-time":"2013-01-26T17:34:17Z","timestamp":1359221657000},"page":"19-27","source":"Crossref","is-referenced-by-count":60,"title":["Lipoprotein apheresis: State of the art and novelties"],"prefix":"10.1016","volume":"14","author":[{"given":"C.","family":"Stefanutti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Julius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosissup.2012.10.021_bib1","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1526-0968.2003.00120.x","article-title":"State of art of LDL-apheresis in the year 2003","volume":"8","author":"Bosch","year":"2004","journal-title":"Ther Apher Dial"},{"issue":"2","key":"10.1016\/j.atherosclerosissup.2012.10.021_bib2","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.atherosclerosis.2008.02.009","article-title":"Recommendations for the use of LDL apheresis","volume":"198","author":"Thompson","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosissup.2012.10.021_bib3","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/jca.20240","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice \u2014 evidence-based approach from the apheresis applications Committee of the American Society for Apheresis","volume":"25","author":"Szczepiorkowski","year":"2010","journal-title":"J Clin Apher"},{"key":"10.1016\/j.atherosclerosissup.2012.10.021_bib4","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0140-6736(81)91213-7","article-title":"Application of specific extracorporeal removal of low density lipoprotein in familial hypercolesterolemia","volume":"318","author":"Stoffel","year":"1981","journal-title":"The Lancet"},{"key":"10.1016\/j.atherosclerosissup.2012.10.021_bib5","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/0002-9343(86)90811-9","article-title":"Removal of low-density lipoproteins in patients by extracorporeal immunoadsorption","volume":"80","author":"Saal","year":"1986","journal-title":"Am J Med"},{"key":"10.1016\/j.atherosclerosissup.2012.10.021_bib6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0021-9150(87)90089-X","article-title":"A new low density lipoprotein apheresis system using two dextran sulfate cellulose columns in an automated column regenerating unit (LDL continuous apheresis)","volume":"68","author":"Mabuchi","year":"1987","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.atherosclerosissup.2012.10.021_bib7","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1525-1594.1996.tb04448.x","article-title":"Evaluation of double filtration plasmapheresis, thermofiltration, and low-density lipoprotein adsorptive methods by crossover test in the treatment of familial hypercholesterolemia patients","volume":"20","author":"Suzuki","year":"1996","journal-title":"Artif Organs"},{"issue":"S-6","key":"10.1016\/j.atherosclerosissup.2012.10.021_bib8","first-page":"66","article-title":"Comparison between different techniques of LDL-apheresis","volume":"21","author":"Stefanutti","year":"1997","journal-title":"Int J Artif Organs"},{"key":"10.1016\/j.atherosclerosissup.2012.10.021_bib9","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0002-9149(97)00947-8","article-title":"Long term effects of LDL-apheresis using automated dextran sulfate cellulose adsorption system","volume":"81","author":"Gordon","year":"1998","journal-title":"Am J Cardiol"},{"issue":"12","key":"10.1016\/j.atherosclerosissup.2012.10.021_bib10","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1177\/039139880202501210","article-title":"Intraindividual comparison of two extracorporeal LDL apheresis methods: lipidfiltration and HELP","volume":"25","author":"Julius","year":"2002","journal-title":"Int J Artif Organs"},{"issue":"5","key":"10.1016\/j.atherosclerosissup.2012.10.021_bib11","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1046\/j.1526-0968.2001.00373.x","article-title":"DALI low-density lipoprotein apheresis in homozygous and heterozygous familial hypercholesterolemic patients using low-dose citrate anticoagulation","volume":"5","author":"Stefanutti","year":"2001","journal-title":"Ther Apher"},{"issue":"4","key":"10.1016\/j.atherosclerosissup.2012.10.021_bib12","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/jca.10035","article-title":"Direct adsorption of low-density lipoprotein and lipoprotein(a) from whole blood: results of the first clinical long-term multicenter study using DALI apheresis","volume":"17","author":"Bosch","year":"2002","journal-title":"J Clin Apher"},{"issue":"10","key":"10.1016\/j.atherosclerosissup.2012.10.021_bib13","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1111\/j.1525-1594.1997.tb00453.x","article-title":"LDL-apheresis in a homozygous familial hypercholesterolemic child aged 4.5","volume":"21","author":"Stefanutti","year":"1997","journal-title":"Artif Organs"},{"key":"10.1016\/j.atherosclerosissup.2012.10.021_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/080352501750258793","article-title":"LDL-apheresis in a patient aged 3.5","volume":"90","author":"Stefanutti","year":"2001","journal-title":"Acta Pediatr"},{"issue":"5","key":"10.1016\/j.atherosclerosissup.2012.10.021_bib15","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s11936-004-0027-2","article-title":"Management of hyperlipidemia in the pediatric population","volume":"6","author":"Tonstad","year":"2004","journal-title":"Curr Treat Options Cardiovasc Med"},{"issue":"10","key":"10.1016\/j.atherosclerosissup.2012.10.021_bib16","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1016\/S0022-2275(20)37137-6","article-title":"Decreased production of low density lipoprotein by atorvastatin after apheresis in homozygous familial hypercholesterolemia","volume":"38","author":"Marais","year":"1997","journal-title":"J Lipid Res"},{"issue":"2","key":"10.1016\/j.atherosclerosissup.2012.10.021_bib17","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0021-9150(95)05649-1","article-title":"Plasma mevalonicacid, an index of cholesterol synthesis in\u00a0vivo, and responsiveness to HMG-CoA reductase inhibitors in familial hypercholesterolaemia","volume":"119","author":"Naoumova","year":"1996","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosissup.2012.10.021_bib18","first-page":"3410","article-title":"Atorvastatin augments therapy of homozygous familial hypercholesterolemia by inhibiting up-regulation of cholesterol synthesis after apheresis and bile acid sequestrant","volume":"94","author":"Naoumova","year":"1996","journal-title":"Circulation"},{"issue":"6510","key":"10.1016\/j.atherosclerosissup.2012.10.021_bib19","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1136\/bmj.291.6510.1671","article-title":"Improved survival of patients with homozygous familial hypercholesterolaemia treated with plasma exchange","volume":"291","author":"Thompson","year":"1985","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.atherosclerosissup.2012.10.021_bib20","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/S0002-9149(98)00692-4","article-title":"Long term efficacy of low density lipoprotein apheresis on coronary heart disease in familial hypercholesterolemia. Hokuriku FH LDL-apheresis Study Group","volume":"82","author":"Mabuchi","year":"1998","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.atherosclerosissup.2012.10.021_bib21","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0021-9150(96)05919-9","article-title":"Decreased susceptibility of low-density lipoproteins to in-vitro oxidation after dextran-sulfate LDL-apheresis treatment","volume":"126","author":"Leitinger","year":"1996","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.atherosclerosissup.2012.10.021_bib22","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1042\/CS20000128","article-title":"Acute and long-term effects of low-density lipoprotein (LDL)-apheresis on oxidative damage to LDL and reducing capacity of erythrocytes in patients with severe familial hypercholesterolaemia","volume":"100","author":"Stefanutti","year":"2001","journal-title":"Clin Sci (Lond)"},{"issue":"1","key":"10.1016\/j.atherosclerosissup.2012.10.021_bib23","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1161\/01.CIR.95.1.76","article-title":"Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans","volume":"95","author":"Tamai","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosissup.2012.10.021_bib24","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2796.1993.tb00781.x","article-title":"Different effects of two methods of low density lipoprotein apheresis on the coagulation and fibrinolitic systems","volume":"234","author":"Knisel","year":"1993","journal-title":"J Intern Med"},{"key":"10.1016\/j.atherosclerosissup.2012.10.021_bib25","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/00001721-199606000-00003","article-title":"Activation of coagulation by LDL-apheresis device","volume":"7","author":"Giansante","year":"1996","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"1\u20132","key":"10.1016\/j.atherosclerosissup.2012.10.021_bib26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0009-8981(90)90189-Y","article-title":"Short- and long-term effects of LDL-apheresis on lipoprotein(a) serum levels","volume":"195","author":"Ritter","year":"1990","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.atherosclerosissup.2012.10.021_bib27","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1177\/039139880002300309","article-title":"Intraindividual comparison of the impact of two selective apheresis methods (DALI and HELP) on the coagulation system","volume":"3","author":"Julius","year":"2000","journal-title":"Int J Artif Organs"},{"key":"10.1016\/j.atherosclerosissup.2012.10.021_bib28","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.atherosclerosis.2004.03.011","article-title":"Effects of heparin-mediated extracorporeal low-density lipoprotein precipitation beyond lowering proatherogenic lipoproteins-reduction of circulating proinflammatory and procoagulatory markers","volume":"175","author":"Wang","year":"2004","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.atherosclerosissup.2012.10.021_bib29","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/jca.20223","article-title":"Different inflammatory responses induced by three LDL-lowering apheresis columns","volume":"24","author":"Hovland","year":"2009","journal-title":"J Clin Apher"},{"issue":"4","key":"10.1016\/j.atherosclerosissup.2012.10.021_bib30","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1046\/j.1526-0968.2003.00080.x","article-title":"Changes in C-reactive protein plasma levels during low-density lipoprotein apheresis","volume":"7","author":"Kojima","year":"2003","journal-title":"Ther Apher Dial"},{"issue":"3","key":"10.1016\/j.atherosclerosissup.2012.10.021_bib31","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.cyto.2011.08.027","article-title":"Lipid and low-density-lipoprotein apheresis. Effects on plasma inflammatory profile and on cytokine pattern in patients with severe dyslipidemia","volume":"56","author":"Stefanutti","year":"2011","journal-title":"Cytokine"},{"issue":"3","key":"10.1016\/j.atherosclerosissup.2012.10.021_bib32","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/00002480-198907000-00057","article-title":"Improvement of peripheral circulation by low density lipoprotein adsorption","volume":"35","author":"Agishi","year":"1989","journal-title":"ASAIO Trans"},{"key":"10.1016\/j.atherosclerosissup.2012.10.021_bib33","first-page":"181","article-title":"The impact of H.E.L.P. on haemorheology in peripheral arterial disease","volume":"14","author":"Lechner","year":"1994","journal-title":"Clin Hemorheol"},{"issue":"3","key":"10.1016\/j.atherosclerosissup.2012.10.021_bib34","first-page":"416","article-title":"Coronary atherosclerosis reduced in patients with familial hypercholesterolemia after intensive cholesterol lowering with low-density lipoprotein-apheresis: 1-year follow-up study. The Osaka LDL-apheresis Multicenter Trial Group","volume":"16","author":"Kitabatake","year":"1994","journal-title":"Clin Ther"},{"key":"10.1016\/j.atherosclerosissup.2012.10.021_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0021-9150(92)90170-L","article-title":"Regression of coronary atherosclerosis by combined LDL-apheresis\u00a0and lipid lowering therapy in patients with familial hypercholesterolemia: a multicenter study. The LAARS Investigators","volume":"95","author":"Tatami","year":"1992","journal-title":"Atherosclerosis"},{"issue":"7","key":"10.1016\/j.atherosclerosissup.2012.10.021_bib36","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/S0735-1097(96)00388-9","article-title":"Low density lipoprotein apheresis improves regional myocardial perfusion in patients with hypercholesterolemia and extensive coronary artery disease. LDL-apheresis Atherosclerosis Regression Study (LAARS)","volume":"28","author":"Aengevaeren","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosissup.2012.10.021_bib37","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0021-9150(98)00328-1","article-title":"Effect of intensive lipid lowering by low density lipoprotein apheresis on regression of coronary atherosclerosis in patients with familial hypercholesterolemia: Japan Low Density Lipoprotein Apheresis Coronary Atherosclerosis Prospective Study (L-Caps)","volume":"144","author":"Nishimura","year":"1999","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.atherosclerosissup.2012.10.021_bib38","doi-asserted-by":"crossref","first-page":"330","DOI":"10.2169\/internalmedicine.38.330","article-title":"Secondary prevention with lipid lowering therapy in familial hypercholesterolemia: a correlation between new evolution of stenotic lesion and achieved cholesterol levels after revascularization procedures","volume":"38","author":"Fukuzawa","year":"1999","journal-title":"Intern Med"},{"issue":"15","key":"10.1016\/j.atherosclerosissup.2012.10.021_bib39","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/0002-9149(94)90279-8","article-title":"Prevention of restenosis after percutaneous transluminal coronary angioplasty by reducing lipoprotein(a) levels with low-density lipoprotein apheresis. Low-density Lipoprotein Apheresis Angioplasty Restenosis Trial (L-ART) Group","volume":"73","author":"Daida","year":"1994","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.atherosclerosissup.2012.10.021_bib40","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S1473-0502(03)00101-0","article-title":"Clinical studies to implement rheopheresis for age-related macular degeneration guided by evidence-based-medicine","volume":"29","author":"Klingel","year":"2003","journal-title":"Transfus Apher Sci"},{"issue":"4","key":"10.1016\/j.atherosclerosissup.2012.10.021_bib41","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/lary.20835","article-title":"Treatment with HELP-apheresis in patients suffering from sudden sensorineural hearing loss: a prospective, randomized, controlled study","volume":"120","author":"Bianchin","year":"2010","journal-title":"Laryngoscope"},{"issue":"3","key":"10.1016\/j.atherosclerosissup.2012.10.021_bib42","first-page":"47","article-title":"Familial defective apolipoprotein B100: FDB","volume":"59","author":"Nohara","year":"2001","journal-title":"Nihon Rinsho"},{"issue":"1","key":"10.1016\/j.atherosclerosissup.2012.10.021_bib43","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/1098-1004(2001)17:1<76::AID-HUMU18>3.0.CO;2-Y","article-title":"Eight novel LDL receptor gene mutations among patients under LDL apheresis in Dresden and Leipzig","volume":"17","author":"Bochmann","year":"2001","journal-title":"Hum Mutat"},{"issue":"2\u20133","key":"10.1016\/j.atherosclerosissup.2012.10.021_bib44","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0021-9150(92)90026-D","article-title":"Effective reduction of plasma LDL levels by LDL apheresis in familial defective apolipoprotein B-100","volume":"95","author":"Maher","year":"1992","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.atherosclerosissup.2012.10.021_bib45","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1055\/s-2004-861491","article-title":"Autosomal recessive hypercholesterolemia","volume":"4","author":"Soutar","year":"2004","journal-title":"Semin Vasc Med"},{"issue":"4","key":"10.1016\/j.atherosclerosissup.2012.10.021_bib46","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/0026-0495(95)90052-7","article-title":"Coexisting type III hyperlipoproteinemia and familial hypercholesterolemia: a case report","volume":"44","author":"Sakuma","year":"1995","journal-title":"Metabolism"},{"key":"10.1016\/j.atherosclerosissup.2012.10.021_bib47","doi-asserted-by":"crossref","DOI":"10.1007\/s11789-012-0046-6","article-title":"Current view: indications for extracorporeal lipid apheresis treatment","author":"Schettler","year":"2012","journal-title":"Clin Res Cardiol Suppl"},{"issue":"6","key":"10.1016\/j.atherosclerosissup.2012.10.021_bib48","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1161\/01.STR.27.6.1044","article-title":"Plasma lipoprotein(a) is an independent factor associated with carotid wall thickening in severely but not moderately hypercholesterolemic patients","volume":"27","author":"Baldassarre","year":"1996","journal-title":"Stroke"},{"issue":"23","key":"10.1016\/j.atherosclerosissup.2012.10.021_bib49","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1093\/eurheartj\/ehq386","article-title":"Lipoprotein(a) as a cardiovascular risk factor: current status","volume":"31","author":"Nordestgaard","year":"2010","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.atherosclerosissup.2012.10.021_bib50","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S1567-5688(09)71817-3","article-title":"Cardiovascular events in patients with increased lipoprotein(a) \u2013 retrospective data analysis in an outpatient department of lipid disorders","volume":"10","author":"Tselmin","year":"2009","journal-title":"Atheroscle Suppl"},{"issue":"2","key":"10.1016\/j.atherosclerosissup.2012.10.021_bib51","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.atherosclerosis.2010.07.007","article-title":"Elevated serum lipoprotein(a) as a potential predictor for combined intracranial and extracranial artery stenosis in patients with ischemic stroke","volume":"212","author":"Kim","year":"2010","journal-title":"Atherosclerosis"},{"issue":"9","key":"10.1016\/j.atherosclerosissup.2012.10.021_bib52","doi-asserted-by":"crossref","first-page":"871","DOI":"10.2174\/138161211795428777","article-title":"Lipoprotein(a): medical treatment options for an elusive molecule","volume":"17","author":"Parhofer","year":"2011","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.atherosclerosissup.2012.10.021_bib53","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0009-3084(94)90152-X","article-title":"Heparin extracorporeal LDL precipitation (HELP): an effective apheresis procedure for lowering Lp(a) levels","volume":"67\u201368","author":"Armstrong","year":"1994","journal-title":"Chem Phys Lipids"},{"issue":"9","key":"10.1016\/j.atherosclerosissup.2012.10.021_bib54","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S0026-0495(98)90278-5","article-title":"Therapeutic efficiency of lipoprotein(a) reduction by low-density lipoprotein immunoapheresis","volume":"47","author":"Banyai","year":"1998","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.atherosclerosissup.2012.10.021_bib55","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.transci.2011.11.016","article-title":"Three different LDL apheresis columns efficiently and equally reduce lipoprotein(a) concentrations in patients with familial hypercholesterolemia and small apolipoprotein(a) particles","volume":"46","author":"Hovland","year":"2012","journal-title":"Transfus Apher Sci"},{"issue":"2","key":"10.1016\/j.atherosclerosissup.2012.10.021_bib56","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jacl.2011.11.003","article-title":"Low-density lipoprotein apheresis is effective in reducing lipoprotein(a) levels and in improving symptoms in a patient with refractory angina secondary to accelerated coronary artery disease","volume":"6","author":"Ibrahim","year":"2012","journal-title":"J Clin Lipidol"},{"issue":"1","key":"10.1016\/j.atherosclerosissup.2012.10.021_bib57","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.transci.2009.10.003","article-title":"Treatment of symptomatic hyperLp(a)lipidemia with LDL-apheresis vs. usual care","volume":"42","author":"Stefanutti","year":"2010","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.atherosclerosissup.2012.10.021_bib58","unstructured":"Julius U, Fischer S, Schatz U, Passauer J, Bornstein SR. Why an apheresis center should offer more than one lipoprotein apheresis method. Ther Apher Dial, in press."},{"issue":"3","key":"10.1016\/j.atherosclerosissup.2012.10.021_bib59","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/ncpcardio1456","article-title":"Longitudinal cohort study on the effectiveness of lipid apheresis treatment to reduce high lipoprotein(a) levels and prevent major adverse coronary events","volume":"6","author":"Jaeger","year":"2009","journal-title":"Nat Clin Pract Cardiovasc Med"},{"issue":"1","key":"10.1016\/j.atherosclerosissup.2012.10.021_bib60","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.atherosclerosissup.2012.10.005","article-title":"Differences in the atherogenic risk of patients treated by lipoprotein apheresis according to their lipid pattern","volume":"14","author":"von Dryander","year":"2013","journal-title":"Atheroscler Suppl"},{"issue":"22","key":"10.1016\/j.atherosclerosissup.2012.10.021_bib61","doi-asserted-by":"crossref","first-page":"10187","DOI":"10.1016\/j.biortech.2011.09.029","article-title":"Efficient bioconversion of compactin to pravastatin by the quinoline-degrading microorganism Pseudonocardia carboxydivorans isolated from petroleum-contaminated soil","volume":"102","author":"Lin","year":"2011","journal-title":"Bioresour Technol"},{"issue":"2","key":"10.1016\/j.atherosclerosissup.2012.10.021_bib62","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1365-2710.2009.01085.x","article-title":"A systematic review and meta-analysis on the therapeutic equivalence of statins","volume":"35","author":"Weng","year":"2010","journal-title":"J Clin Pharm Ther"},{"issue":"17","key":"10.1016\/j.atherosclerosissup.2012.10.021_bib63","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.jacc.2011.12.035","volume":"59","author":"Mora","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.atherosclerosissup.2012.10.021_bib64","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/j.1875-9114.2011.01086.x","article-title":"Cholesterol level goal attainment with statins: clinical management guideline recommendations versus management in actual clinical practice","volume":"32","author":"Heintjes","year":"2012","journal-title":"Pharmacotherapy"},{"issue":"5A","key":"10.1016\/j.atherosclerosissup.2012.10.021_bib65","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0002-9149(01)01452-7","article-title":"Novel approaches to lipid lowering: what is on the horizon?","volume":"87","author":"Brown","year":"2001","journal-title":"Am J Cardiol"},{"issue":"8","key":"10.1016\/j.atherosclerosissup.2012.10.021_bib66","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1021\/jm901909p","article-title":"A novel class of antihyperlipidemic agents with low density lipoprotein receptor up-regulation via the adaptor protein autosomal recessive hypercholesterolemia","volume":"53","author":"Asano","year":"2010","journal-title":"J Med Chem"},{"issue":"1 Suppl.","key":"10.1016\/j.atherosclerosissup.2012.10.021_bib67","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.amjcard.2012.04.003","article-title":"Recent clinical studies of the effects of lipid-modifying therapies","volume":"110","author":"Gotto","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosissup.2012.10.021_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2012.02.019","article-title":"Homozygous familial hypercholesterolemia: current perspectives on diagnosis and treatment","author":"Raal","year":"2012","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.atherosclerosissup.2012.10.021_bib69","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1056\/NEJMoa061189","article-title":"Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia","volume":"356","author":"Cuchel","year":"2007","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.atherosclerosissup.2012.10.021_bib70","first-page":"469","article-title":"Impact of the MTP-inhibitor, AEGR-733, as monotherapy and in combination with ezetimibe on lipid subfractions as measured by NMR spectroscopy","volume":"118","author":"Samaha","year":"2008","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.atherosclerosissup.2012.10.021_bib71","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.atherosclerosis.2011.04.018","article-title":"Clinical aspects of PCSK9","volume":"216","author":"Cariou","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosissup.2012.10.021_bib72","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1517\/14728220802600715","article-title":"PCSK9 as a therapeutic target of dyslipidemia","volume":"13","author":"Seidah","year":"2009","journal-title":"Expert Opin Ther Targets"},{"issue":"2","key":"10.1016\/j.atherosclerosissup.2012.10.021_bib73","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1517\/14728222.2011.547480","article-title":"PCSK9: an emerging target for treatment of hypercholesterolemia","volume":"15","author":"Duff","year":"2011","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.atherosclerosissup.2012.10.021_bib74","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1161\/CIRCULATIONAHA.105.606442","article-title":"Potent reduction of apolipoprotein B and LDL cholesterol by short-term administration of an antisense inhibitor of apolipoprotein B","volume":"114","author":"Kastelein","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosissup.2012.10.021_bib75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0021-9150(02)00251-4","article-title":"LDL apheresis","volume":"167","author":"Thompson","year":"2003","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.atherosclerosissup.2012.10.021_bib76","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.transci.2004.01.010","article-title":"Therapeutic apheresis in low weight patients: technical feasibility, tolerance, compliance, and risks","volume":"31","author":"Stefanutti","year":"2004","journal-title":"Transfus Apher Sci"},{"issue":"10","key":"10.1016\/j.atherosclerosissup.2012.10.021_bib77","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.numecd.2010.04.007","article-title":"The 2009 2nd Italian consensus conference on LDL-apheresis","volume":"20","author":"Stefanutti","year":"2010","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"7","key":"10.1016\/j.atherosclerosissup.2012.10.021_bib78","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1111\/j.1537-2995.2009.02135.x","article-title":"Aorta and coronary angiographic follow-up of children with severe hypercholesterolemia treated with low-density lipoprotein apheresis","volume":"49","author":"Stefanutti","year":"2009","journal-title":"Transfusion"},{"issue":"13","key":"10.1016\/j.atherosclerosissup.2012.10.021_bib79","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJMoa0804602","article-title":"SEAS Investigators: intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis","volume":"359","author":"Rosseb\u00f8","year":"2008","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.atherosclerosissup.2012.10.021_bib80","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1056\/NEJMc082192","article-title":"Calcific aortic stenosis","volume":"360","author":"Pazianas","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosissup.2012.10.021_bib81","first-page":"1","article-title":"Prevention of calcific aortic valve stenosis fact or fiction?","volume":"14","author":"Cawley","year":"2009","journal-title":"Ann Med"},{"issue":"3","key":"10.1016\/j.atherosclerosissup.2012.10.021_bib82","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1046\/j.1526-0968.2003.00066.x","article-title":"Differential indication of lipoprotein apheresis during pregnancy","volume":"7","author":"Klingel","year":"2003","journal-title":"Ther Apher Dial"},{"issue":"10","key":"10.1016\/j.atherosclerosissup.2012.10.021_bib83","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/S0002-9149(00)01183-8","article-title":"Low-density lipoprotein apheresis therapy during pregnancy","volume":"86","author":"Cashin-Hemphill","year":"2000","journal-title":"Am J Cardiol"},{"issue":"7","key":"10.1016\/j.atherosclerosissup.2012.10.021_bib84","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/0026-0495(95)90247-3","article-title":"Pregnancy in a patient with homozygous familial hypercholesterolemia undergoing low-density lipoprotein apheresis by dextran sulfate adsorption","volume":"44","author":"Teruel","year":"1995","journal-title":"Metabolism"},{"issue":"1\u20132","key":"10.1016\/j.atherosclerosissup.2012.10.021_bib85","first-page":"412","article-title":"LDL-apheresis in the treatment of familial hypercholesterolemia in childhood","volume":"134","author":"Stefanutti","year":"1997","journal-title":"Atherosclerosis"}],"container-title":["Atherosclerosis Supplements"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567568812000323?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567568812000323?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,6]],"date-time":"2022-02-06T21:18:20Z","timestamp":1644182300000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567568812000323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":85,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S1567568812000323"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosissup.2012.10.021","relation":{},"ISSN":["1567-5688"],"issn-type":[{"value":"1567-5688","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}